The results from this study demonstrated that there was no relation between the relative expression of NPC1 and the amount of cholesterol that flowed through the coated-pit pathway. We conclude that the relative expression of NPC1 is not regulated by the flow of cholesterol through cells in the mouse, and is therefore constitutive.
INTRODUCTION
Niemann-Pick C1 (NPC1) disease is an autosomal recessive lipid storage disorder characterized by hepatosplenomegaly and progressive neurodegeneration (1) . The gene responsible for NPC1 disease has been identified in both humans and mice, with the encoded protein being designated as the Niemann-Pick C1 (NPC1) protein (2, 3) . The predicted amino acid sequence of NPC1 was shown to contain a number of structural motifs that include i) a signal-peptide at the amino-terminus for endoplasmic reticulum insertion, ii) a highly conserved cysteine-rich region with a leucine zipper referred to as the NPC1 domain, iii) five transmembrane domains that represent a sterol-sensing domain homologous to other proteins (HMG-CoA reductase, SCAP and NPC1L1) involved in regulating cholesterol metabolism, and iv) a dileucine motif at the carboxylterminus that mediates targeting of proteins to late endosomes/lysosomes (4) (5) (6) (7) (8) .
Mutational analysis of the NPC1 gene has revealed that mutations residing within both the NPC1 domain or sterol-sensing domain are particularly susceptible to adversely affecting the function of NPC1 and thereby causing NPC1 disease (9) (10) (11) (12) . The NPC1 mouse model has proven to be a valuable tool for investigating the function of NPC1 in regulating cholesterol metabolism. Early studies performed using the NPC1 mouse described an accumulation of cholesterol in the liver and a defect in the esterification of lipoprotein-derived cholesterol, in addition to the development of hepatomegaly when these mice were fed a cholesterol-rich diet (13, 14) . Subsequent studies determined that the NPC1 mutation results in a time-dependent accumulation of cholesterol in nearly every tissue of the mouse, so that when the NPC1 mouse reaches 7-weeks of age, the whole-body pool of cholesterol is increased 2.5-fold (approximately by guest, on August 15, 2017 www.jlr.org Downloaded from 4 5,400 mg/kg body weight) compared to a normal mouse (approximately 2,200 mg/kg body weight) (15) . The one tissue of the NPC1 mouse that seemingly does not accumulate cholesterol, the central nervous system, actually also participates in the accumulation of cholesterol. However, unlike the other tissues, progressive neurodegeneration results in a simultaneous loss of myelin cholesterol, which essentially masks the cellular accumulation of cholesterol within cells of the central nervous system (16, 17) .
The accumulation of cholesterol in the NPC1 mouse has been shown to result from endocytosis of total cholesterol carried in both chylomicron remnants (CMr-TC) and low density lipoproteins (LDL-TC) through the coated-pit pathway (15, 18) . In contrast, studies indicate that cholesterol derived from other sources, such as cholesterol synthesis and uptake of cholesteryl ester carried in high density lipoproteins (HDL-CE) through the scavenger receptor-class B, type I (SR-BI) pathway, does not contribute to the accumulation of cholesterol in the NPC1 mouse (19) . Although endocytosis and processing of CMr-TC and LDL-TC by cells with deficient NPC1 activity has been characterized by an accumulation of cholesterol within late endosomes/lysosomes, the rate of cholesterol synthesis in these cells is increased suggesting an overall defect in the regulation of intracellular cholesterol homeostasis (20) (21) (22) . More recent studies have determined that cholesterol transport from late endosomes/lysosomes to specialized regions of the Golgi apparatus and plasma membrane for efflux to apolipoprotein A-I and formation of HDL, are also adversely affected in cells with deficient NPC1 activity (23) (24) (25) (26) . A schematic representation of the major pathways for the movement of cholesterol through different cells in the body is shown (Fig. 1). by guest, on August 15, 2017 www.jlr.org
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Consistent with results indicating a block in the transport of CMr-TC and LDL-TC, studies performed using both human and mouse fibroblasts incubated in the presence of LDL demonstrate that NPC1 is primarily associated with novel late endosomal compartments that transiently interact with cholesterol-enriched late endosomes/lysosomes (27, 28) . These novel NPC1-containing compartments have been shown to be multivesicular in nature, enriched with lysobisphosphatidic acid (LBPA), and also contain the cholesterol-binding protein MLN-64 that is associated with the limiting membrane (28) (29) (30) . The sterol-sensing domain of NPC1 has recently been shown to directly bind cholesterol, therefore suggesting that the NPC1 compartment in general serves as a sterol-modulated lipid-sorting compartment that regulates the retrograde transport of endocytosed cholesterol and glycolipids (31, 32) . The transport of endocytosed lipids, which requires NPC1 to have a functional sterol-sensing domain, has been described as a dynamic process involving the rapid migration of NPC1 along microtubules (33, 34) .
The present studies were performed to determine the relative expression of NPC1 in relation to the flow of cholesterol through cells in the mouse. The first experiment was performed to determine the relative expression of NPC1 protein in livers and cerebrums of mice from different genetic backgrounds. Results indicate that the relative expression of NPC1 protein in these tissues were approximately the same. As a result, the BALB/c mouse strain was used throughout the remainder of the study to conduct additional experiments. The second two sets of experiments measured the relative expression of NPC1 mRNA and NPC1 protein in the various tissues of the mouse. The relative expression of NPC1 protein in these tissues, including five regions of the central nervous by guest, on August 15, 2017 www.jlr.org Downloaded from 6 system, were compared to the combined rates of CMr-TC and LDL-TC uptake through the coated-pit pathway, and also the combined rates of cholesterol synthesis and HDL-CE uptake through the SR-BI pathway. The relative expression of NPC1 mRNA and NPC1 protein were then determined in relation to the flow of cholesterol through the coated-pit pathway by supplementing diets with increasing amounts of cholesterol or cholestyramine. Together, the results obtained from this study indicate that although the relative expression of NPC1 mRNA and NPC1 protein varied markedly among various tissues of the mouse, the flow of cholesterol through the cells in the mouse does not regulate the relative expression of NPC1.
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MATERIALS AND METHODS
Animals
The Institute Animal Care and Research Advisory Committee at the University of Texas Southwestern Medical Center approved the studies described in this report. The BALB/c mouse that was primarily used in this study was generated from an inbred colony. Other mice from different genetic backgrounds (DBA, C57BL/6, FVB/NJ, and 129/Sv) that were used in one experiment were purchased from the Jackson Laboratory (Bar Harbor, ME). The mice were housed in plastic colony cages in rooms with alternating 12-h periods of light and dark. Most mice were fed ad libitum and maintained on a low cholesterol (0.016% w/w) basal rodent diet (No. 7001, Harlan Teklad, Madison, WI). In one study, mice were fed ad libitum a low cholesterol basal rodent diet supplemented with 0.1% cholesterol, 1% cholesterol, or 2% cholestyramine. All studies were performed on mice at seven weeks of age in the fed state at the mid-dark phase of the light cycle.
Isolation and radiolabeling of LDL and HDL
Mouse plasma was harvested from both male and female NPC1 +/+ / LDLR -/-mice maintained on a low cholesterol basal rodent diet (35) . The LDL and HDL fractions were isolated using preparative ultracentrifugation in the density ranges of 1.020-1.055 g/ml and 1.070-1.210 g/ml, respectively. The LDL fraction was radiolabeled with either 125 Ilabeled tyramine cellobiose or 131 I, followed by passage through a heparin-Sepharose CL-6B column (Pharmacia Biotech, Uppsala, Sweden) to remove any contaminating apoEcontaining HDL (35, 36 
Measurement of LDL and HDL clearance rates in vivo
The mice were anesthetized at the mid-dark phase of the light cycle with diethyl ether and xylazine and a catheter was inserted into the jugular vein. After awakening, the mice were administered a bolus of 125 I-labeled tyramine cellobiose-labeled LDL followed by a continuous infusion of the same preparation for 4 h at a rate determined to maintain a constant specific activity within the plasma (19, 35 
Measurement of cholesterol synthesis rates in vivo
The rates of cholesterol synthesis for each tissue were measured in vivo at the mid-dark phase of the light cycle. The mice were injected intraperitoneally with approximately 50 mCi of [ 3 H]-water contained in 100 µl isotonic saline solution (45) (46) (47) .
One hour later the mice were anesthetized, exsanguinated, and the tissues were removed.
These tissues and remaining carcass were saponified, and the digitonin precipitable sterols were isolated (45, 46) . The rates of sterol synthesis in each tissue were calculated and expressed as the nanomoles of 
Measurement of intestinal cholesterol absorption
Cholesterol absorption was measured by a modified fecal dual-isotope ratio method using [4- Aliquots of ground stool and the dosing mixture were extracted, and the ratio of 14 C and
Northern blot analysis
Total RNA was obtained from mouse tissue using RNA STAT60 (Tel-Test, Inc., Friendswood, TX), and the mRNA was isolated using oligo(dT)-cellulose columns (Pharmacia Biotech, Uppsala, Sweden). The isolated mRNA was prepared by pooling equal quantities of total hepatic RNA from six mice per treatment group, 5 µg/lane was size-fractionated on 1% formaldehyde agarose gels and transferred to Zetaprobe nylon membranes (BioRad Laboratories, Hercules, CA). A cDNA fragment of mouse NPC1
was generated by reverse transcription-polymerase chain reaction (RT-PCR) using the following primers: NPC1-F, 5'ggtgctggacagccaagta and NPC1-R, 5'tcagccagtccttcagcag, along with mouse brain total RNA as a template. The resulting PCR product contained nucleotides #1605-2629 of the mouse NPC1 sequence (GenBank ACC# NM_008720).
Rat cyclophilin cDNA was kindly provided by David Russell (University of Texas
Southwestern Medical Center). The 32 P-labeled cDNA probes were prepared using the Rediprime II Random Prime labeling system and unincorporated 32 P-dCTP was removed with a G50 spin column. The Northern blot membranes were hybridized with the radiolabeled probes and the NPC1 bands (5.8 kb) were quantitated using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) normalized against cyclophilin.
Tissue homogenization and protein determination
Mouse tissues were homogenized in ice-cold hypotonic homogenization buffer containing 10 mM sodium phosphate pH 7.4 and a complete protease inhibitor cocktail parts ice-cold solubilization buffer containing 10 mM sodium phosphate pH 7.4, 150 mM NaCl, 1.0% Triton X-100, 10 mM SDS and a complete protease inhibitor cocktail. This solubilization mixture was placed onto a rotating rack in the cold-room and allowed to mix for a period of 30 min. In preparation for immunoblot analysis, the concentration of solubilized protein was determined using the bicinchoninic acid (BCA) protein assay method (Pierce-Endogen, Rockford, IL) with BSA as a standard.
Immunoblot analysis
An equivalent amount of solubilized protein (50 µg) from each sample was separated using 6.0% sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) under reduced conditions and transferred to a nitrocellulose membrane (51).
Immunoblot buffer containing 10 mM sodium phosphate pH 7.4, 150 mM NaCl, 0.05%
Tween-20 and 5% non-fat dry milk was used to block nonspecific sites on the membrane for a period of 2 h. The membrane was then incubated in the presence of immunoblot buffer containing NPC1 antibody in the cold-room while mixing overnight (28 
RESULTS
Relative expression of NPC1 protein in the liver and cerebrum of mice from different genetic backgrounds
It is well recognized that there are marked differences in the metabolism of cholesterol by different strains of mice (52, 53) . Using immunoblot analysis to measure the amount of NPC1 protein, this study was performed to determine the relative expression of NPC1 protein in livers and cerebrums of mice from six different genetic backgrounds (BALB/c, DBA, C57BL/6, FVB/NJ, mixed, and 129/Sv) (Fig. 2) . The results indicate that although there were significant differences in the relative expression of NPC1 protein in livers and cerebrums between some mice of different genetic backgrounds, overall the relative expression of NPC1 protein in these tissues was similar.
With respect to livers, the largest difference in the relative mean expression of NPC1
protein occurred between FVB/NJ and mixed mice, where the FVB/NJ mouse livers expressed approximately 40% more NPC1 protein than the mixed mouse livers ( Fig. 2A) .
With respect to cerebrums, the largest difference in the relative mean expression of NPC1 protein occurred between BALB/c and mixed mice, where the BALB/c mouse cerebrums expressed approximately 25% more NPC1 protein than the mixed mouse cerebrums (Fig.   2B ). Since the relative expression of NPC1 protein in livers and cerebrums from BALB/c mice were approximately the same between most mice of the different genetic backgrounds, the remaining studies were performed using only the BALB/c strain of mouse.
Relative expression of NPC1 mRNA in different tissues of the mouse
It has been shown that NPC1 mice accumulate excess cholesterol in every tissue, including cells of the central nervous system (15, 16, 18) . In this study, the relative expression of NPC1 mRNA in the different tissues of the mouse was determined using
Northern blot analysis (Fig. 3) . The relative expression of cyclophilin mRNA was also determined and used as a loading control for total mRNA. The relative expression of While the latter study demonstrated that NPC1 mRNA was expressed in nearly all tissues, the next study was performed to determine the relative expression of NPC1
protein in relation to the rate of cholesterol flowing through the two major pathways 16 described in Fig. 1 (Fig. 4) . In this study, the relative expression of NPC1 protein was determined using nine different tissues (Fig. 4A) , including five different regions of the central nervous system (Fig. 4B) . uptake occurred in the liver (Fig. 4C) , while there was little or no detectable uptake of CMr-TC and LDL-TC in other organs (Fig. 4C) , particularly in regions of the central nervous system (Fig. 4D) . The second major pathway for cholesterol flowing through these cells represents the selective uptake of cholesteryl esters carried in HDL (HDL-CE)
utilizing SR-BI, and de novo cholesterol synthesis (Fig. 1) . Again, the rates for both these processes were quantitated and then combined. As expected, the major site for the selective uptake of HDL-CE and cholesterol synthesis was the liver (Fig. 4E) , while the remaining tissues (Fig. 4E ), including regions of the central nervous system (Fig. 4F ), had lower rates of selective uptake and cholesterol synthesis. Therefore, these results clearly demonstrate that the highest flow of cholesterol through the coated-pit pathway was in the liver (Fig. 4C) , while a much lower or absent flow of cholesterol through the coated-pit pathway was present in the remaining tissues (Fig. 4C) , including the central nervous system (Fig. 4D) . Nevertheless, the NPC1 protein was substantially expressed in nearly all tissues (Fig. 4A) , including regions of the central nervous system (Fig. 4B) , which correlated poorly, if at all, with cholesterol flowing through the coated pit pathway in these tissues.
Relative expression of NPC1 mRNA in relation to the flow of cholesterol through the coated-pit pathway in the liver
To determine if the relative expression of NPC1 mRNA is regulated by the flow of cholesterol through the coated-pit pathway of the liver, mice were fed diets supplemented with either increasing amounts of cholesterol or cholestyramine (Fig. 5) .
At 7 weeks of age, one group of mice were fed a low cholesterol basal rodent diet, while (27, 28) .
In the present study, the relative expression of NPC1 mRNA and NPC1 protein was determined in relation to the flow of cholesterol through the coated-pit pathway using two different methods. First, the relative expression of NPC1 protein in different tissues of the mouse was compared to the relative uptake of CMr-TC and LDL-TC in these tissues, where the results indicated no correlation. Second, the relative expression of NPC1 mRNA and NPC1 protein in the liver and cerebrum of the mouse was compared to the flow of cholesterol through the coated-pit pathway by supplementing diets with 23 increasing amounts of cholesterol or cholestyramine. As noted in this and previous studies, when mice are fed a diet containing an increased amount of cholesterol, the total concentration of cholesterol in the liver and fecal bile excretion increases, while mice fed a diet containing cholestyramine causes an increase in cholesterol 7α-hydroxylase activity and fecal bile excretion, together indicating that both increased cholesterol and cholestyramine result in an increased flow of cholesterol through cells in the liver (19, 49) . This being true, results from the present study indicate that when mice are fed a diet with increasing amounts of cholesterol or cholestyramine, the relative expression of NPC1 mRNA in the liver is not significantly altered. This result was confirmed with the relative expression of NPC1 protein, in both the liver and cerebrum, not being significantly altered when mice were fed a diet with increasing amounts of cholesterol or cholestyramine. Therefore, as a result this study strongly suggests that the relative expression of NPC1 is not regulated by the flow of cholesterol through the cell, and that NPC1 is constitutively expressed in relation to the amount of cholesterol.
In the second pathway that was described in Fig. 1 , referred to as the SR-BI pathway, the SR-BI facilitates selective uptake of cholesteryl ester from HDL-CE into the cell. The internalized cholesteryl ester is then hydrolyzed in an undefined compartment, resulting in the release of cholesterol (40, 60) . This cholesterol mixes with newly synthesized cholesterol and enters the metabolically active pool of cholesterol destined for excretion from the cell. As studies have already shown, the mutation of NPC1 does not adversely affect the flow of cholesterol through the SR-BI pathway (19) . Moreover, as the present study indicates, neither is the relative expression of NPC1 protein affected by guest, on August 15, 2017 
